About Lipur Pharmaceuticals
Lipur Pharmaceuticals is a company. Lipur Pharmaceuticals offers products and services including Arnilow 50 and Amoxlip 625.
-
Sectors
Healthcare
-
Phone
Locked
- Legal Name Lipur Pharmaceuticals Private Limited
- Jurisdiction Patna, Bihar, India
-
Annual Revenue
$301.48 K (USD)87.41as on Mar 31, 2023
-
Net Profit
$2.05 K (USD)44.12as on Mar 31, 2023
-
EBITDA
$1.51 K (USD)-44.33as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lipur Pharmaceuticals
Lipur Pharmaceuticals offers a comprehensive portfolio of products and services, including Arnilow 50 and Amoxlip 625.
Arnilow 50 is distributed as a generic drug for medical use, with quality controlled according to established standards.
Amoxlip 625 is offered as another generic drug, adhering to manufacturing guidelines for healthcare purposes.
Funding Insights of Lipur Pharmaceuticals
Detailed funding history for Lipur Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lipur Pharmaceuticals
Investment portfolio details for Lipur Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lipur Pharmaceuticals
Detailed financials for Lipur Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lipur Pharmaceuticals Comparisons
Peer comparison for Lipur Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lipur Pharmaceuticals
Detailed competitors of Lipur Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lipur Pharmaceuticals
Complete news archive for Lipur Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lipur Pharmaceuticals
Annual revenue of Lipur Pharmaceuticals is $301.48K as on Mar 31, 2023.
Lipur Pharmaceuticals is recognized as a distributor of generic drugs in India, where cost-effective medicines are provided to customers while balancing quality and feasibility. World-class standards in manufacturing and quality control are adhered to, and authentic medicines are dispensed following legal guidelines. Discounts on prescribed items and healthcare devices are made available, with operations supported by over 12 years of experience and more than 50 products. The company is headquartered in Patna, facilitating access with an intuitive interface.
Lipur Pharmaceuticals offers Arnilow 50 and Amoxlip 625.